Jul 11 |
Novo’s once-weekly insulin rejected by FDA
|
Jul 11 |
Better Growth Play: Eli Lilly vs. Vanguard Growth Index Fund ETF Shares
|
Jul 11 |
Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
|
Jul 10 |
FTC plans to sue top 3 PBMs over insulin prices: WSJ
|
Jul 10 |
FTC to Sue Drug Managers Over Insulin Prices
|
Jul 10 |
FTC to sue drug managers amid insulin price hikes
|
Jul 10 |
Eli Lilly names Gordon Brooks as interim CFO
|
Jul 10 |
Analysts revamp Eli Lilly stock price target ahead of Q2 earnings
|
Jul 10 |
Market Chatter: Analysis Shows Use of Novo Nordisk's Wegovy, Ozempic for Weight Loss Declines After Two Years
|
Jul 10 |
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds
|